CVS HEALTH Corp (CVS) stock
Close on Nov 11, 2026Market cap $114.49BP/E 10.4Yield 2.97%
CVS HEALTH Corp grew revenue 6.7% to $420.61B over the twelve months to Sep 30, 2026. Operating income rose 206.4% to $15.06B, moving the operating margin from 1.2% to 3.6%. Free cash flow was $15.57B, up 147.4% from a year earlier. At the latest close the market valued the company at $114.49B, 10.4 times its earnings.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $114.49B
- P/E ratio
- 10.4
- Price to sales
- 0.27
- Price to book
- 1.42
- Dividend yield
- 2.97%
- Free cash flow yield
- 13.60%
Fundamentals
- Revenue
- $420.61B
- Net income
- $11.04B
- EPS, diluted
- $8.58
- Free cash flow
- $15.57B
- Book value per share
- $62.35
- Diluted shares
- 1.29B
Trading
- Next earnings
- Feb 9, 2027 (estimated, before the open)
- Previous close
- $89.01
- Open
- $88.80
- Day's range
- $87.45 – $90.00
- Volume
- 11,082,230
- Average volume (20 days)
- 11,100,082
- Index membership
- S&P 500, Russell 1000, Russell 3000
- Beta (5 years)
- 0.49
- 52-week range
- $69.51 – $110.68
- RSI (14 days)
- 51.4
- Volatility (1 year)
- 34.1%
- Relative volume
- 1.28×
- WACC
- 6.4%
On 1 of our idea list: Superinvestor favorites
Index membership is inferred from the holdings of funds that track each index (VOO, IVV, SPYM, IWB, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2009, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | CVS | S&P 500 | Difference | CVS per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +3.9% | -2.4% | +6.3 pts | ||
| 3 months | -4.3% | -1.2% | −3.1 pts | ||
| Year to date | +15.4% | +12.3% | +3.1 pts | ||
| 1 year | +14.7% | +12.4% | +2.3 pts | ||
| 3 years | +47.1% | +78.8% | −31.8 pts | +13.7% | +21.4% |
| 5 years | +11.5% | +75.2% | −63.7 pts | +2.2% | +11.9% |
| 10 years | +61.5% | +311.1% | −249.6 pts | +4.9% | +15.2% |
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Cvs Health filed with the SEC as exhibits to Form 8-K or 6-K
- Update
- Results
- Update
- Results
- Results
- Results
About Cvs Health
Retail-Drug Stores and Proprietary Stores
CVS Health Corporation is a diversified healthcare solutions enterprise providing health insurance, pharmacy services, and medical care delivery. The company conducts business through four reportable segments: Health Care Benefits, Health Services, Pharmacy & Consumer Wellness, and Corporate/Other. Through its Aetna operations, CVS Health offers commercial, Medicare Advantage, Medicare Part D prescription drug, and Medicaid health plans, alongside dental, behavioral health, and supplemental coverage. Through its CVS Caremark operations, the organization administers pharmacy benefit management solutions, including plan design, formulary oversight, and specialty and mail-order dispensing. Its customers encompass individual health plan members, employer groups, labor unions, commercial health plans, government programs, healthcare providers, and patients receiving care directly.
Company profile, executives and historyCvs Health stock: common questions
What is Cvs Health's stock price?
CVS closed at $89.52 on Nov 11, 2026, up 0.57% on the day. Over the past 52 weeks it traded between $69.51 and $110.68.
What is Cvs Health's market cap?
Cvs Health was worth $114.49B at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is CVS's P/E ratio?
CVS trades at 10.4 times earnings, based on diluted earnings per share of $8.58 over the twelve months to Sep 30, 2026.
How much revenue does Cvs Health make?
Cvs Health reported revenue of $420.61B for the twelve months to Sep 30, 2026, up 6.7% from a year earlier.
Does Cvs Health pay a dividend?
Yes. Cvs Health paid $2.66 per share over the last twelve months, a yield of 2.97% at the latest price.
When does Cvs Health report earnings next?
Cvs Health is expected to report Q4 FY2026 results on Feb 9, 2027, before the open. The date is estimated from its past reporting pattern until the company confirms it.
How has CVS stock performed over the past year?
Including dividends, CVS returned +14.7% over the past year, against +12.4% for the S&P 500.
How many CVS shares are sold short?
18M shares were sold short at the latest FINRA report, 1.40% of the float, or 2.8 days of average trading volume.
Who are Cvs Health's competitors?
Companies most similar to Cvs Health by business, industry and size include CI, UNH, ELV, CAH, CNC.
See a number that looks wrong?